Fagron Compounding Services Recalls

2 recalls found for Fagron Compounding Services. Check if any of your products are affected.

HIGHFDA DRUG

Fagron Compounds Recalls Bevacizumab Injection Over Sterility Risk

Fagron Compounding Services recalled 109,320 syringes of bevacizumab (Avastin) on August 29, 2025. The recall follows a lack of assurance of sterility, posing a high health risk. Consumers and healthcare providers should stop using the product immediately.

Fagron Compounding Services
Lack of
Read more

Brand Statistics

Total Recalls
2
Pages
1